// App-Quantinova.ai

2443 : Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Post-Transplantation Cyclophosphamide: Assessing the Importance of Conditioning Regimen, Donor Choice, and Tyrosine Kinase Inhibitor Use

Researchers

Presenter

  • Jonathan Webster

Principal Investigators

  • Hua-Ling Tsai

  • Philip H. Imus

  • Amy E. DeZern

  • Keith W. Pratz

  • Mark Levis

  • Ivana Gojo

  • Margaret M. Showel

  • Gabrielle T. Prince

  • Javier Bolanos-Meade

  • Lukasz P. Gondek

  • Gabriel Ghiaur

  • William Brian Dalton

  • Tania Jain

  • Ephraim J. Fuchs

  • Douglas E Gladstone

  • Christian B. Gocke

  • Abbas Abbas Ali

  • Carol Ann Huff

  • Ivan M. Borrello

  • Lode J. Swinnen

  • Nina D. Wagner-Johnston

  • Richard F. Ambinder

  • Richard J. Jones

  • B. Douglas Smith

Medical Centers

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Sidney Kimmel Comp Cancer Ctr, Baltimore, MD

  • Oncology Biostatistics and Bioinformatics, Johns Hopkins University, Baltimore, MD

  • Department of Medicine, Hematology-Oncology Section, Hospital of the University of Pennsylvania, Philadelphia, PA

  • Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine,, Baltimore, MD

  • The Johns Hopkins Hospital, Baltimore, MD

  • Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Kimmel Cancer Center, Ellicott City, MD

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

  • Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins/Sidney Kimmel Cancer Center, Baltimore, MD

  • Division of Medical Oncology, Johns Hopkins Cancer Center, Baltimore, MD

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Johns Hopkins Medical Institutions, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved